Skip to main content
2021-01-13
Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products
2021-01-06
Guidance for Naming of Medicinal Products
2020-12-08
Top Deficiencies in Validation and Assessment Phases of Herbal and Health Products
2020-12-01
Guideline For Good Clinical Practice (GCP) E6(R2)
2020-11-23
The GCC Guidance for Presenting the Labeling Information, SPC and PIL
2020-11-23
Templates for Labeling information, SPC and PIL
2020-11-10
Guidelines for Variation Requirements
2020-08-27
Drug Master File : Guidance for Submission
Displaying 1 - 9 of 17